We are live on ! Find out more
RXD icon

ProShares UltraShort Health Care
RXD

2 hedge funds and large institutions have $371K invested in ProShares UltraShort Health Care in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more call options, than puts

Call options by funds: $33.6M | Put options by funds: $10.9M

22.12% less ownership

Funds ownership: 37.8% → 15.68% (-22%)

25% less capital invested

Capital invested by funds: $493K → $371K (-$122K)

50% less funds holding

Funds holding: 4 → 2 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
–
Closed
2
Calls
$33.6M
Puts
$10.9M
Net Calls
+$22.7M
Net Calls Change
+$13.6M

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$40.2K
2
FTUS
Flow Traders U.S.
New York
+$3.74K

Top Sellers

Rank Fund Capital Flow
1
IP
Intellectus Partners
California
-$79K
2
UBS Group
UBS Group
Switzerland
-$20K

RXD Hedge Fund Activity: Q2 2021 in Review

2 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q2 2021, worth a combined $371K — down 25% from $493K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of RXD and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Susquehanna International Group, adding an estimated $40.2K. The largest seller was Intellectus Partners, exiting entirely with an estimated $79K sold.

  • 2 institutional investors held ProShares UltraShort Health Care (RXD) as of Q2 2021, down from 4 in Q1 2021.
  • Funds reported $371K of ProShares UltraShort Health Care stock for Q2 2021, down 25% quarter-over-quarter.
  • 0 funds opened new ProShares UltraShort Health Care positions in Q2 2021 and 2 closed out, a net change of -2 holders.
  • The largest ProShares UltraShort Health Care buyer in Q2 2021 was Susquehanna International Group, an estimated $40.2K added.
  • The largest ProShares UltraShort Health Care seller in Q2 2021 was Intellectus Partners, an estimated $79K sold.

Based on aggregated 13F filings for Q2 2021.